Biomerica Inc. (BMRA)
0.58
-0.04 (-6.30%)
At close: Mar 28, 2025, 3:59 PM
0.61
4.21%
After-hours: Mar 28, 2025, 06:30 PM EDT
-6.30% (1D)
| Bid | 0.58 |
| Market Cap | 10.71M |
| Revenue (ttm) | 5.97M |
| Net Income (ttm) | -6M |
| EPS (ttm) | -0.33 |
| PE Ratio (ttm) | -1.77 |
| Forward PE | 1.75 |
| Analyst | n/a |
| Ask | 0.65 |
| Volume | 271,915 |
| Avg. Volume (20D) | 7,670,851 |
| Open | 0.62 |
| Previous Close | 0.62 |
| Day's Range | 0.58 - 0.64 |
| 52-Week Range | 0.24 - 1.27 |
| Beta | -1.17 |
About BMRA
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies...
Industry Medical - Devices
Sector Healthcare
IPO Date Sep 7, 1984
Employees 64
Stock Exchange NASDAQ
Ticker Symbol BMRA
Website https://www.biomerica.com
1 month ago
+9.39%
Biomerica shares are trading higher after the comp...
Unlock content with
Pro Subscription
2 months ago
+101.71%
Biomerica shares are trading higher after the company announced its Fortel Prostate Specific Antigen Screening Test received approval from the United Arab Emirates Ministry of Health and Prevention.
